Jeff Baxter, VBI's President and CEO, sat down with Henry Truc, Executive Editor for Equities.com, to discuss VBI, the vaccine landscape, and CMV. The interview was conducted last month at the Small-Cap Stars Conference at the NASDAQ MarketSite in Times Square. Equities.com Disclaimer...

About VBI Vaccines

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. Learn More >>